about
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseasePathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levelsSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaThe clinical use of structural MRI in Alzheimer diseaseGenome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseFrontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological featuresWord-finding difficulty: a clinical analysis of the progressive aphasias.The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.Brain imaging in Alzheimer diseaseImaging markers for Alzheimer disease: which vs howEffect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx studyAtrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trialsGenetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's diseaseAccuracy of dementia diagnosis: a direct comparison between radiologists and a computerized methodThe diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseCommon variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseClinical and biomarker changes in dominantly inherited Alzheimer's disease.White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration.Mapping the progression of progranulin-associated frontotemporal lobar degenerationNothing to say, something to sing: primary progressive dynamic aphasia.Regional variability of imaging biomarkers in autosomal dominant Alzheimer's diseasePreclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial.Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions.Standardization of analysis sets for reporting results from ADNI MRI dataNeuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.Computer-assisted imaging to assess brain structure in healthy and diseased brains.Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion.A data-driven model of biomarker changes in sporadic Alzheimer's disease.The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial.Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2Magnetic resonance imaging measures of brain atrophy in multiple sclerosis.Imaging cadavers: cold FLAIR and noninvasive brain thermometry using CSF diffusionLongitudinal imaging in dementia.A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus.Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data.HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.Brain-water diffusion coefficients reflect the severity of inherited prion disease.Genetic variability in CLU and its association with Alzheimer's disease.Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.
P50
Q22251067-E7BB0E90-FFA4-4052-B0C7-152EB2492304Q24336201-A43FB032-2D46-452E-B653-92724DD6417AQ24598142-C5023D87-C726-48E2-A11F-391B67D75A27Q24609648-EFD399C7-2441-4ED9-A177-66A1A6EBB065Q24612662-E66C29B0-B883-49A5-9902-A2EA4049C3D0Q24630410-3F18DFEE-1710-45A4-92ED-227DE842792CQ24644914-DF2DA2ED-6D5E-4114-AED4-0B7BA448A674Q24647259-52CCB58D-1EC5-45AD-A056-FC1C778069FFQ26996299-04F89DED-C084-490B-AEF1-559EC33F7BEBQ27001254-D73C2C2B-3C6E-46B4-B820-93D8C19ADD79Q28302829-D4377CEB-56D4-4C0F-89E7-8D932F156C5EQ28488143-CE362CCB-7331-4F2E-BA38-3B4D106558DDQ28748461-2C8D8191-3102-4EC5-9B09-AB973B697C08Q28756638-1AF99E06-F743-4750-9A63-D08B14E29EABQ29614406-E2C29D3D-FF12-4AD4-9C6D-299C9A700854Q29614879-FBB4D52A-0EDD-4D6B-B004-FEC74B63426CQ29619940-35530C51-70A8-48AC-8BF6-726271001761Q30405893-5E493F1A-AEA0-4756-9EE0-16142315BED0Q30484077-4F4E42BD-A7D0-49C6-8827-98C8AC42B509Q30540491-603D71F0-4E9B-4268-9AB5-2EA2BF08AEF4Q30557788-99372DBF-0967-4515-8C85-22ED40B5AF67Q30561855-F0674E62-0A23-4AF2-92C1-592524A65421Q30570437-0976C8AB-C6AA-49FE-BF71-E124CA14A031Q30575373-422B5B79-4F80-4576-850E-279AC51F07DEQ30655992-4F5C4271-24F1-41CC-9CF1-08DBB4843264Q30810182-FB6580A3-35A6-4B10-9A4B-378AC6AE7138Q30810310-6121D53B-8FD2-4824-BB46-B1F9E3675A38Q30835966-5AEEA506-B39A-4784-AF27-B3C15320D36FQ30874688-ED65E683-C2E1-4125-B5E2-BB96D44295E0Q30931423-1CA355CF-A752-4068-A0E8-30CD697A835AQ30981669-1BFBD2C4-F470-488C-A48D-EF266916B1F6Q31036129-DE8DFCF9-9047-4121-AF68-5B7A0AA56B11Q31138908-928DB32A-DDE3-4BA4-8264-D872BDCBAD89Q31153983-2B895821-009B-40CD-91B0-F8E5E3D4759CQ33324572-35993318-E44D-45FC-A6C7-CDBB74DAFDCEQ33489152-B22005EC-7F6F-4A5A-9833-6537719DD457Q33503386-713D3A19-66F8-43FA-8D3D-6B6186FC987CQ33533558-DFEB1F67-3D6A-422B-B551-7A2F12764B43Q33538000-F4DEB8E0-B469-44E5-BF64-65E1B61833BCQ33540910-B80043E2-991F-4C17-8980-049519A741FA
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Nick C Fox
@nl
Nick C Fox
@sl
Nick C. Fox
@en
Nick C. Fox
@es
type
label
Nick C Fox
@nl
Nick C Fox
@sl
Nick C. Fox
@en
Nick C. Fox
@es
altLabel
Nick C Fox
@en
Nick Fox
@en
prefLabel
Nick C Fox
@nl
Nick C Fox
@sl
Nick C. Fox
@en
Nick C. Fox
@es
P1053
B-1319-2009
P106
P1153
55571481700
P21
P214
3054149368882685980004
P2456
P31
P3829
P496
0000-0002-6660-657X
P734
P735
P7859
lccn-n00121922